| - GRCh37:
- Chr15:60120659-102461201
- GRCh38:
- Chr15:59828460-101920998
| AAGAB, ABHD17C, ABHD2, ACAN, ACSBG1, ADAMTS17, ADAMTS7, ADAMTSL3, ADPGK, ADPGK-AS1, AEN, AGBL1, AGBL1-AS1, AKAP13, ALDH1A3, ALDH1A3-AS1, ALPK3, ANKDD1A, ANKRD34C, ANKRD34C-AS1, ANP32A, ANP32A-IT1, ANPEP, ANXA2, AP3B2, AP3S2, APH1B, ARID3B, ARIH1, ARNT2, ARNT2-DT, ARPIN, ARPIN-AP3S2, ARRDC4, ASB7, BBS4, BCL2A1, BLM, BNC1, BTBD1, C15orf32, C15orf39, C15orf40, C15orf61, C2CD4A, C2CD4B, CA12, CALML4, CARMAL, CCDC33, CD276, CELF6, CEMIP, CERS3, CERS3-AS1, CFAP161, CHASERR, CHD2, CHRNA3, CHRNA5, CHRNB4, CHSY1, CIAO2A, CIB1, CIB2, CILP, CLK3, CLN6, CLPX, COMMD4, CORO2B, COX5A, CPEB1, CPEB1-AS1, CPLX3, CRABP1, CRAT37, CRTC3, CRTC3-AS1, CSK, CSNK1G1, CSPG4, CT62, CTSH, CTXND1, CYP11A1, CYP1A1, CYP1A2, DAPK2, DENND4A, DET1, DIS3L, DIS3L-AS1, DNAJA4, DNAJA4-DT, DPP8, DRAIC, EDC3, EFL1, ETFA, EWSAT1, FAH, FAM174B, FAM219B, FANCI, FBXL22, FBXO22, FBXO22-AS1, FEM1B, FES, FOXB1, FSD2, FURIN, GCAWKR, GDPGP1, GLCE, GOLGA6A, GOLGA6B, GOLGA6C, GOLGA6D, GOLGA6L10, GOLGA6L4, GOLGA6L9, GRAMD2A, HACD3, HAPLN3, HCN4, HDDC3, HDGFL3, HERC1, HEXA, HEXA-AS1, HIGD2B, HMG20A, HOMER2, HYKK, ICE2, IDH2, IDH2-DT, IDH3A, IGDCC3, IGDCC4, IGF1R, IL16, IMP3, INSYN1, INSYN1-AS1, INTS14, IQCH, IQCH-AS1, IQGAP1, IRAIN, IREB2, ISG20, ISL2, ISLR, ISLR2, ITGA11, KBTBD13, KIF23, KIF23-AS1, KIF7, KLHL25, LACTB, LARP6, LCTL, LETR1, LINC00052, LINC00593, LINC00597, LINC00923, LINC00924, LINC00927, LINC00928, LINC00930, LINC00933, LINC01169, LINC01418, LINC01579, LINC01580, LINC01581, LINC01582, LINC01583, LINC01584, LINC01585, LINC01586, LINC02204, LINC02205, LINC02207, LINC02244, LINC02251, LINC02253, LINC02254, LINC02255, LINC02259, LINC02348, LINC02349, LINC02351, LINC02568, LINC02883, LINGO1, LINGO1-AS1, LINGO1-AS2, LINS1, LMAN1L, LOC100128979, LOC100129540, LOC100507472, LOC101927310, LOC101928988, LOC101929439, LOC101929457, LOC101929586, LOC102723335, LOC102724034, LOC102724452, LOC103171574, LOC104613533, LOC105369212, LOC105370954, LOC105370980, LOC105371031, LOC107984784, LOC107988046, LOC107992387, LOC108251791, LOC108281191, LOC108964933, LOC110120860, LOC110120861, LOC110120917, LOC110121345, LOC110121383, LOC110121430, LOC110121464, LOC110121491, LOC110121492, LOC110467515, LOC110467516, LOC110467517, LOC111365216, LOC111413015, LOC111413032, LOC111413043, LOC111562369, LOC111718493, LOC111822949, LOC112272574, LOC112272602, LOC112272603, LOC112272604, LOC112272605, LOC112272606, LOC112272607, LOC112272608, LOC112272609, LOC112272610, LOC112272613, LOC112272614, LOC112272615, LOC112272616, LOC112272617, LOC112272618, LOC112272619, LOC112272620, LOC112272621, LOC112272622, LOC112272623, LOC112296173, LOC112296174, LOC112296175, LOC112296176, LOC112296177, LOC112296178, LOC113939942, LOC113939945, LOC113939946, LOC113939947, LOC114827858, LOC116268467, LOC116268468, LOC116268469, LOC116268470, LOC116268471, LOC116268472, LOC116268473, LOC116268474, LOC116268475, LOC116268476, LOC116268477, LOC116268478, LOC116268479, LOC117204000, LOC117204001, LOC120285840, LOC121530585, LOC121530586, LOC121530587, LOC121530588, LOC121530589, LOC121530590, LOC121530591, LOC121530592, LOC121530593, LOC121530594, LOC121530595, LOC121530596, LOC121530597, LOC121530598, LOC121530599, LOC121530600, LOC121530601, LOC121530602, LOC121530603, LOC121530604, LOC121530605, LOC121847953, LOC121847954, LOC121847955, LOC121847956, LOC121847957, LOC121847958, LOC121847959, LOC121847960, LOC121847961, LOC121847962, LOC121847963, LOC121847964, LOC121847965, LOC121847966, LOC125078089, LOC125078090, LOC125078091, LOC125078093, LOC125078094, LOC125078095, LOC125078096, LOC125078097, LOC125078098, LOC125078099, LOC125078100, LOC125078101, LOC125078102, LOC125078103, LOC125078104, LOC125110343, LOC125110344, LOC125110345, LOC125110346, LOC125110347, LOC125110348, LOC125110349, LOC125110350, LOC125110351, LOC125110352, LOC125110353, LOC125110354, LOC125110355, LOC125110356, LOC125110357, LOC125138289, LOC125138290, LOC125138291, LOC125138292, LOC125138293, LOC125138294, LOC125138295, LOC125138296, LOC125138297, LOC125138298, LOC125138299, LOC125138300, LOC125138301, LOC125138302, LOC125138303, LOC125138305, LOC125138306, LOC125138307, LOC125138308, LOC125138309, LOC125146351, LOC125146353, LOC125146354, LOC125146355, LOC125146356, LOC125146357, LOC125146359, LOC125146360, LOC125146361, LOC125146362, LOC125146363, LOC125146364, LOC125146365, LOC125146367, LOC125146368, LOC125146369, LOC125146370, LOC126862143, LOC126862144, LOC126862145, LOC126862146, LOC126862147, LOC126862148, LOC126862149, LOC126862150, LOC126862151, LOC126862152, LOC126862153, LOC126862154, LOC126862155, LOC126862156, LOC126862157, LOC126862158, LOC126862159, LOC126862160, LOC126862161, LOC126862162, LOC126862163, LOC126862164, LOC126862165, LOC126862166, LOC126862167, LOC126862168, LOC126862169, LOC126862170, LOC126862171, LOC126862172, LOC126862173, LOC126862174, LOC126862175, LOC126862176, LOC126862177, LOC126862178, LOC126862179, LOC126862180, LOC126862181, LOC126862182, LOC126862183, LOC126862184, LOC126862185, LOC126862186, LOC126862187, LOC126862188, LOC126862189, LOC126862190, LOC126862191, LOC126862192, LOC126862193, LOC126862194, LOC126862195, LOC126862196, LOC126862197, LOC126862198, LOC126862199, LOC126862200, LOC126862201, LOC126862202, LOC126862203, LOC126862204, LOC126862205, LOC126862206, LOC126862207, LOC126862208, LOC126862209, LOC126862210, LOC126862211, LOC126862212, LOC126862213, LOC126862214, LOC126862215, LOC126862216, LOC126862217, LOC126862218, LOC126862219, LOC126862220, LOC126862221, LOC126862222, LOC126862223, LOC126862224, LOC126862225, LOC126862226, LOC126862227, LOC126862228, LOC126862229, LOC126862230, LOC126862231, LOC126862232, LOC126862233, LOC126862234, LOC126862235, LOC126862236, LOC126862237, LOC126862238, LOC126862239, LOC126862240, LOC126862241, LOC126862242, LOC126862243, LOC126862244, LOC126862245, LOC126862246, LOC126862247, LOC126862248, LOC126862249, LOC126862250, LOC126862251, LOC126862252, LOC126862253, LOC126862254, LOC126862255, LOC126862256, LOC126862257, LOC126862258, LOC126862259, LOC128071545, LOC283731, LOC91450, LOXL1, LOXL1-AS1, LRRC28, LRRC49, LRRK1, LUNAR1, LYSMD4, MAN2A2, MAN2C1, MAP2K1, MAP2K5, MCTP2, MEF2A, MEGF11, MESD, MESP1, MESP2, MEX3B, MFGE8, MGC15885, MINAR1, MIR11181, MIR1179, MIR12135, MIR1272, MIR1276, MIR1469, MIR184, MIR190A, MIR3174, MIR3175, MIR3529, MIR3713, MIR422A, MIR4311, MIR4312, MIR4313, MIR4511, MIR4512, MIR4513, MIR4514, MIR4515, MIR4714, MIR5009, MIR5094, MIR548AP, MIR549A, MIR5572, MIR6085, MIR629, MIR630, MIR631, MIR6766, MIR6881, MIR6882, MIR7-2, MIR7706, MIR8067, MIR9-3, MIR9-3HG, MORF4L1, MPI, MRPL46, MRPS11, MTFMT, MTHFS, MYO9A, NEIL1, NEO1, NGRN, NMB, NOX5, NPTN, NPTN-IT1, NR2E3, NR2F2, NR2F2-AS1, NRG4, NTRK3, NTRK3-AS1, OAZ2, ODF3L1, OR4F15, OR4F6, PAQR5, PAQR5-DT, PARP16, PARP6, PCAT29, PCLAF, PCSK6, PCSK6-AS1, PDCD7, PDE8A, PEAK1, PEX11A, PGPEP1L, PIAS1, PIF1, PIRC76, PKM, PLEKHO2, PLIN1, PML, POLG, POLGARF, PPCDC, PPIB, PRC1, PRC1-AS1, PSMA4, PSTPIP1, PTPN9, RAB11A, RAB8B, RAMAC, RASGRF1, RASL12, RBPMS2, RCCD1, RCCD1-AS1, RCN2, REC114, RGMA, RHCG, RLBP1, RNU5A-1, RNU5B-1, RNU6-1, RORA, RORA-AS1, RORA-AS2, RPL4, RPLP1, RPP25, RPS17, RPS27L, SALRNA2, SALRNA3, SAXO2, SCAMP2, SCAMP5, SCAPER, SCARNA14, SCARNA15, SEC11A, SELENOS, SEMA4B, SEMA7A, SENP8, SH2D7, SH3GL3, SLC51B, SIN3A, SKIC8, SKOR1, SKOR1-AS1, SLC24A1, SLC28A1, SLCO3A1, SMAD3, SMAD3-DT, SMAD6, SMASR, SNAPC5, SNHG21, SNORA24B, SNORD13E, SNORD16, SNORD18A, SNORD18B, SNORD18C, SNRPA1, SNRPA1-DT, SNUPN, SNX1, SNX22, SNX33, SPATA41, SPATA8, SPATA8-AS1, SPESP1, SPG21, ST20, ST20-AS1, ST20-MTHFS, ST8SIA2, STARD5, STOML1, STRA6, SV2B, SYNM, SYNM-AS1, TARS3, TBC1D21, TBC1D2B, THAP10, THSD4, THSD4-AS1, THSD4-AS2, TICRR, TIPIN, TLE3, TLN2, TLNRD1, TM2D3, TM6SF1, TMC3, TMC3-AS1, TMED3, TMEM202, TMEM202-AS1, TMEM266, TPM1, TPM1-AS, TRC-GCA5-1, TRIP4, TRK-CTT1-2, TRQ-CTG1-4, TRR-TCG1-1, TSPAN3, TTC23, TTLL13, UACA, UBAP1L, UBE2Q2, UBL7, UBL7-DT, ULK3, UNC45A, USP3, USP3-AS1, VPS13C, VPS13C-DT, VPS33B, VPS33B-DT, WDR73, WDR93, WHAMM, ZFAND6, ZNF592, ZNF609, ZNF710, ZNF710-AS1, ZNF774, ZSCAN2, ZWILCH | | See cases | Pathogenic (Oct 24, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr15:66678919
- GRCh38:
- Chr15:66386581
| MAP2K1, TIPIN | | not provided | Benign (Jun 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66678991
- GRCh38:
- Chr15:66386653
| MAP2K1, TIPIN | | not provided | Benign (Jun 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679055
- GRCh38:
- Chr15:66386717
| TIPIN, MAP2K1 | | not provided | Benign (Jun 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679139
- GRCh38:
- Chr15:66386801
| MAP2K1 | | not provided | Likely benign (Jun 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679238
- GRCh38:
- Chr15:66386900
| MAP2K1 | | not provided | Likely benign (Jul 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679464-66679465
- GRCh38:
- Chr15:66387126-66387127
| MAP2K1 | | not provided, Cardio-facio-cutaneous syndrome, Noonan syndrome
| Likely benign (Oct 16, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679574-66679575
- GRCh38:
- Chr15:66387236-66387237
| MAP2K1 | | not provided | Likely benign (Nov 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679601
- GRCh38:
- Chr15:66387263
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679643
- GRCh38:
- Chr15:66387305
| MAP2K1 | | not provided | Likely benign (Feb 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679649-66679650
- GRCh38:
- Chr15:66387311-66387312
| MAP2K1 | | not specified | Benign (Apr 15, 2014) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679684
- GRCh38:
- Chr15:66387346
| MAP2K1 | | Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified, not provided, RASopathy | Benign (Jul 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679690
- GRCh38:
- Chr15:66387352
| MAP2K1 | P2R | RASopathy | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679691
- GRCh38:
- Chr15:66387353
| MAP2K1 | | RASopathy | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679691
- GRCh38:
- Chr15:66387353
| MAP2K1 | | Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified, not provided, RASopathy | Benign/Likely benign (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679696
- GRCh38:
- Chr15:66387358
| MAP2K1 | K4R | not provided | Uncertain significance (Mar 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679697
- GRCh38:
- Chr15:66387359
| MAP2K1 | | RASopathy, Cardiovascular phenotype | Likely benign (Sep 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679700
- GRCh38:
- Chr15:66387362
| MAP2K1 | | not specified, RASopathy | Likely benign (May 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679714
- GRCh38:
- Chr15:66387376
| MAP2K1 | Q10L | not specified | Uncertain significance (Aug 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679718
- GRCh38:
- Chr15:66387380
| MAP2K1 | | RASopathy | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679721
- GRCh38:
- Chr15:66387383
| MAP2K1 | | not provided | Likely benign (Jun 25, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679722
- GRCh38:
- Chr15:66387384
| MAP2K1 | P13S | not provided | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679724
- GRCh38:
- Chr15:66387386
| MAP2K1 | | RASopathy, not specified | Likely benign (Apr 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679726
- GRCh38:
- Chr15:66387388
| MAP2K1 | D16fs | not provided | Uncertain significance (Sep 16, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr15:66679727
- GRCh38:
- Chr15:66387389
| MAP2K1 | | not provided | Uncertain significance (Dec 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679728
- GRCh38:
- Chr15:66387390
| MAP2K1 | P15A | Cardiovascular phenotype | Uncertain significance (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679728
- GRCh38:
- Chr15:66387390
| MAP2K1 | P15S | RASopathy | Uncertain significance (Aug 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679730
- GRCh38:
- Chr15:66387392
| MAP2K1 | | Cardiovascular phenotype | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679733
- GRCh38:
- Chr15:66387395
| MAP2K1 | D16E | RASopathy | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679738
- GRCh38:
- Chr15:66387400
| MAP2K1 | S18C | not provided | Uncertain significance (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679741
- GRCh38:
- Chr15:66387403
| MAP2K1 | A19G | not specified, RASopathy | Uncertain significance (Mar 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66679754
- GRCh38:
- Chr15:66387416
| MAP2K1 | | RASopathy | Likely benign (May 9, 2017) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr15:66679755
- GRCh38:
- Chr15:66387417
| MAP2K1 | S24G | RASopathy | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679756
- GRCh38:
- Chr15:66387418
| MAP2K1 | S24T | RASopathy | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679761
- GRCh38:
- Chr15:66387423
| MAP2K1 | A26T | not provided | Uncertain significance (Oct 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679762
- GRCh38:
- Chr15:66387424
| MAP2K1 | A26V | RASopathy | Uncertain significance (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679774
- GRCh38:
- Chr15:66387436
| MAP2K1 | | RASopathy | Likely benign (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679779
- GRCh38:
- Chr15:66387441
| MAP2K1 | | not provided | Likely benign (Apr 22, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679781
- GRCh38:
- Chr15:66387443
| MAP2K1 | | RASopathy | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679783-66679784
- GRCh38:
- Chr15:66387445-66387446
| MAP2K1 | | RASopathy | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679793
- GRCh38:
- Chr15:66387455
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679798
- GRCh38:
- Chr15:66387460
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679798
- GRCh38:
- Chr15:66387460
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679819
- GRCh38:
- Chr15:66387481
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679850
- GRCh38:
- Chr15:66387512
| MAP2K1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679851
- GRCh38:
- Chr15:66387513
| MAP2K1 | | not provided | Benign (Jun 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679958
- GRCh38:
- Chr15:66387620
| MAP2K1 | | not provided | Benign (Jul 27, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727345
- GRCh38:
- Chr15:66435007
| MAP2K1 | | RASopathy | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727352
- GRCh38:
- Chr15:66435014
| MAP2K1 | | RASopathy | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727370
- GRCh38:
- Chr15:66435032
| MAP2K1 | N29S, N7S | RASopathy | Uncertain significance (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727379
- GRCh38:
- Chr15:66435041
| MAP2K1 | A10V, A32V | Cardiovascular phenotype | Uncertain significance (Jul 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727383
- GRCh38:
- Chr15:66435045
| MAP2K1 | | RASopathy | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727392
- GRCh38:
- Chr15:66435054
| MAP2K1 | | not provided, RASopathy | Likely benign (Sep 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727408
- GRCh38:
- Chr15:66435070
| MAP2K1 | L42F | not specified, Cardio-facio-cutaneous syndrome | Conflicting interpretations of pathogenicity (Aug 27, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:66727409
- GRCh38:
- Chr15:66435071
| MAP2K1 | L20R, L42R | not provided | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727410-66727412
- GRCh38:
- Chr15:66435072-66435074
| MAP2K1 | D43del | RASopathy | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727413-66727445
- GRCh38:
- Chr15:66435075-66435107
| MAP2K1 | | RASopathy | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727419
- GRCh38:
- Chr15:66435081
| MAP2K1 | Q45H | not provided | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727421
- GRCh38:
- Chr15:66435083
| MAP2K1 | Q46L | Cardio-facio-cutaneous syndrome | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr15:66727423
- GRCh38:
- Chr15:66435085
| MAP2K1 | R25*, R47* | not provided | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727424
- GRCh38:
- Chr15:66435086
| MAP2K1 | R47Q | not specified, RASopathy | Uncertain significance (Jun 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727430
- GRCh38:
- Chr15:66435092
| MAP2K1 | R27H, R49H | RASopathy | Uncertain significance (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727431
- GRCh38:
- Chr15:66435093
| MAP2K1 | | RASopathy | Likely benign (Dec 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727433
- GRCh38:
- Chr15:66435095
| MAP2K1 | L50P | not provided | Pathogenic (Jan 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727437
- GRCh38:
- Chr15:66435099
| MAP2K1 | | RASopathy | Likely benign (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727440
- GRCh38:
- Chr15:66435102
| MAP2K1 | | Cardiovascular phenotype, not specified | Likely benign (Mar 16, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727440
- GRCh38:
- Chr15:66435102
| MAP2K1 | | not specified, not provided, RASopathy
| Benign/Likely benign (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727441
- GRCh38:
- Chr15:66435103
| MAP2K1 | F53I | Gastric adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Lung adenocarcinoma | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727441
- GRCh38:
- Chr15:66435103
| MAP2K1 | F53V | Gastric adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Lung adenocarcinoma | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727441
- GRCh38:
- Chr15:66435103
| MAP2K1 | F53L | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727442
- GRCh38:
- Chr15:66435104
| MAP2K1 | F53S | Cardio-facio-cutaneous syndrome | Pathogenic (May 9, 2017) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr15:66727443
- GRCh38:
- Chr15:66435105
| MAP2K1 | F53L | Neoplasm of the large intestine, Gastric adenocarcinoma, Malignant melanoma of skin, Lung adenocarcinoma | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727445
- GRCh38:
- Chr15:66435107
| MAP2K1 | L54P | RASopathy | Pathogenic (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727451
- GRCh38:
- Chr15:66435113
| MAP2K1 | Q56P | not provided | Pathogenic (Jul 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727453
- GRCh38:
- Chr15:66435115
| MAP2K1 | K57E | Melanoma, Melorheostosis | Pathogenic/Likely pathogenic (Jun 23, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727453
- GRCh38:
- Chr15:66435115
| MAP2K1 | K57Q | RASopathy | Likely pathogenic (May 9, 2017) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr15:66727454
- GRCh38:
- Chr15:66435116
| MAP2K1 | K35M, K57M | not provided | Pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727454
- GRCh38:
- Chr15:66435116
| MAP2K1 | K57T | Prostate adenocarcinoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Non-Hodgkin lymphoma, Lung adenocarcinoma, Gastric adenocarcinoma
| Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727455
- GRCh38:
- Chr15:66435117
| MAP2K1 | K57N | Prostate adenocarcinoma, Malignant melanoma of skin, Lung adenocarcinoma, Non-Hodgkin lymphoma, Squamous cell carcinoma of the head and neck, Gastric adenocarcinoma, Melanoma | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727455
- GRCh38:
- Chr15:66435117
| MAP2K1 | K57N | not provided | Pathogenic (Apr 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727456-66727470
- GRCh38:
- Chr15:66435118-66435132
| MAP2K1 | | Parkes Weber syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727457-66727459
- GRCh38:
- Chr15:66435119-66435121
| MAP2K1 | K59del | not provided, RASopathy | Likely pathogenic (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727458
- GRCh38:
- Chr15:66435120
| MAP2K1 | Q58H | Cardiofaciocutaneous syndrome 3 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr15:66727458-66727472
- GRCh38:
- Chr15:66435120-66435134
| MAP2K1 | | not provided | Likely pathogenic (Mar 8, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727461
- GRCh38:
- Chr15:66435123
| MAP2K1 | | RASopathy, not specified | Benign/Likely benign (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727463
- GRCh38:
- Chr15:66435125
| MAP2K1 | V60G | not provided | Uncertain significance (Jul 10, 2012) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727468-66727482
- GRCh38:
- Chr15:66435130-66435144
| MAP2K1 | | not provided | Likely pathogenic (Mar 8, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727482
- GRCh38:
- Chr15:66435144
| MAP2K1 | D66E | RASopathy | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727482
- GRCh38:
- Chr15:66435144
| MAP2K1 | | RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype
| Conflicting interpretations of pathogenicity (Sep 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:66727483
- GRCh38:
- Chr15:66435145
| MAP2K1 | D67N | Cardio-facio-cutaneous syndrome | Pathogenic (May 9, 2017) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr15:66727489
- GRCh38:
- Chr15:66435151
| MAP2K1 | E69K | RASopathy | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727496
- GRCh38:
- Chr15:66435158
| MAP2K1 | I71T | RASopathy | Uncertain significance (Jul 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727496
- GRCh38:
- Chr15:66435158
| MAP2K1 | I71S | RASopathy | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727499
- GRCh38:
- Chr15:66435161
| MAP2K1 | S50N, S72N | RASopathy | Uncertain significance (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727518
- GRCh38:
- Chr15:66435180
| MAP2K1 | | RASopathy | Likely benign (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727521
- GRCh38:
- Chr15:66435183
| MAP2K1 | | Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified, RASopathy, Noonan syndrome 1, Cardiofaciocutaneous syndrome 3, Melorheostosis | Benign/Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727522
- GRCh38:
- Chr15:66435184
| MAP2K1 | G80S | RASopathy | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727535
- GRCh38:
- Chr15:66435197
| MAP2K1 | K84R | not specified, Noonan syndrome and Noonan-related syndrome, not provided, RASopathy | Uncertain significance (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66727539
- GRCh38:
- Chr15:66435201
| MAP2K1 | | RASopathy | Likely benign (Dec 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727539
- GRCh38:
- Chr15:66435201
| MAP2K1 | | RASopathy, Cardiovascular phenotype | Likely benign (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |